NCT06322511 Dialogical Family Guidance PostDoc Study
| NCT ID | NCT06322511 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Tampere University |
| Condition | Family Dynamics |
| Study Type | INTERVENTIONAL |
| Enrollment | 50 participants |
| Start Date | 2024-01-02 |
| Primary Completion | 2027-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 50 participants in total. It began in 2024-01-02 with a primary completion date of 2027-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This new family intervention, called Dialogical Family Guidance (DFG) is developed to target family needs especially in families with a child with neurodevelopmental disorders. PhD study showed, that this intervention is functioning with this target group. Participants (families) experienced that they got information, guidance to ordinary life and that the DFG-therapists were listening to them and above all, helping with individual problems and questions. DFG include six meetings and professionals need to attend on a 3-day long education before using this intervention.
Eligibility Criteria
Inclusion Criteria: * Families with a child with clinical diagnosis within neurodevelopmental ambrella (ADHD, Tourette, Autism disorder, OCD...). * the child must be between 4-13 years. Exclusion Criteria: * Families who do not understand finnish language (because they can not fill the questionnaires and professionals offering DFG are all finnish speaking). At least one parent needs to talk finnish. * Families who are not motivated to receive DFG. * Families who do not have a child with neurodevelopmental disorders.
Contact & Investigator
Diana Cavonius-Rintahaka, PhD
PRINCIPAL INVESTIGATOR
Tampere University, Finland
Frequently Asked Questions
Who can join the NCT06322511 clinical trial?
This trial is open to participants of all sexes, aged 4 Years or older, up to 13 Years, studying Family Dynamics. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06322511 currently recruiting?
Yes, NCT06322511 is actively recruiting participants. Contact the research team at diana.cavonius@gmail.com for enrollment information.
Where is the NCT06322511 trial being conducted?
This trial is being conducted at Helsinki, Finland.
Who is sponsoring the NCT06322511 clinical trial?
NCT06322511 is sponsored by Tampere University. The principal investigator is Diana Cavonius-Rintahaka, PhD at Tampere University, Finland. The trial plans to enroll 50 participants.